NOS2 and diabetes mellitus: Altered iNOS-derived NO production has been involved in the beginning of acute and chronic inflammatory conditions associated with diverse diseases, including arthritis, sepsis, ischemia/reperfusion, diabetes, and atherosclerosis (63).